Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes

2022-05-05T18:34:12+00:00April 11th, 2022|

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes Overall Survival CONTACT US Summary This trial investigated the efficacy and safety of this DC-based [...]

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes

2022-04-11T16:52:15+00:00April 11th, 2022|

Adoptive Immunotherapy for Pancreatic Cancer Using MUC1 Peptide-pulsed Dendritic Cells and Activated T Lymphocytes CT scans CONTACT US Summary This study aims to determine the clinical efficacy of immunotherapy [...]

Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival

2022-04-11T16:41:13+00:00April 11th, 2022|

Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival Overall Survival CONTACT US Summary This trial [...]

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

2022-04-11T16:24:18+00:00April 11th, 2022|

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study Survival time CONTACT US Summary [...]

Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer

2022-04-11T16:30:59+00:00April 11th, 2022|

Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer Survival probability CONTACT US Summary This study evaluated the effect of 13.56 MHz modulated electro-hyperthermia [...]

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer

2022-04-11T10:07:44+00:00April 11th, 2022|

Clinical outcome of immunotherapy with dendritic cell vaccine and cytokine‐induced killer cell therapy in hepatobiliary and pancreatic cancer Overall survival CONTACT US Summary The goal of this study was [...]

Go to Top